XCUR · NASDAQ
Exicure (XCUR) Stock Price & Fundamentals
Exicure (XCUR) closed at $565.86 on Oct 9, 2026, down 0.06% from the previous close of $566.22.
Share price, past year
1Y +16.28%Monthly closing prices
| Date | Close |
|---|---|
| Oct 9, 2026 | $565.86 |
| Sep 30, 2026 | $555.61 |
| Aug 31, 2026 | $539.72 |
| Jul 31, 2026 | $554.25 |
| Jun 30, 2026 | $581.23 |
| May 29, 2026 | $583.28 |
| Apr 30, 2026 | $538.41 |
| Mar 31, 2026 | $525.14 |
| Feb 27, 2026 | $525.20 |
| Jan 30, 2026 | $514.57 |
| Dec 31, 2025 | $498.73 |
| Nov 28, 2025 | $500.63 |
| Oct 31, 2025 | $473.30 |
Key statistics
- Market cap
- $3.61B
- P/E (TTM)
- —
- EPS (TTM)
- −$1.34
- Revenue (TTM)
- $0.00
- Net income (TTM)
- −$8.28M
- Shares outstanding
- 6.4M
- Dividend yield
- —
- 52-week range
- $469.95 – $597.84
Exicure's market cap is $3.61B, based on a share price of $565.86 and 6.4M shares outstanding as of Jun 30, 2026.
Financials
Exicure reported revenue of $0.00 for fiscal 2025, down 100.00% from fiscal 2024.
Exicure reported a net loss of $4.95M in fiscal 2025.
Annual revenue
| Fiscal year | Revenue | Growth | Net income | Net margin | EPS (diluted) | Free cash flow |
|---|---|---|---|---|---|---|
| FY2025ended Dec 31, 2025 | $0.00 | −100.0% | −$4.95M | — | −$0.79 | −$8.56M |
| FY2024ended Dec 31, 2024 | $500.00K | — | −$9.70M | −1,940.2% | −$4.75 | −$2.91M |
| FY2023ended Dec 31, 2023 | $0.00 | −100.0% | −$16.91M | — | −$10.55 | −$10.36M |
| FY2022ended Dec 31, 2022 | $28.83M | +6,068.1% | −$2.58M | −9.0% | −$2.80 | −$35.67M |
| FY2021ended Dec 31, 2021 | −$483.00K | −102.9% | −$64.10M | 13,271.6% | −$108.50 | −$35.79M |
| FY2020ended Dec 31, 2020 | $16.61M | +1,181.9% | −$24.67M | −148.5% | −$42.04 | −$42.44M |
| FY2019ended Dec 31, 2019 | $1.30M | +998.3% | −$26.30M | −2,029.6% | −$69.07 | $235.00K |
| FY2018ended Dec 31, 2018 | $118.00K | −98.8% | −$22.41M | −18,994.1% | −$81.08 | −$19.58M |
| FY2017ended Dec 31, 2017 | $9.72M | +838.1% | −$11.01M | −113.3% | −$163.66 | −$20.72M |
| FY2016ended Dec 31, 2016 | $1.04M | — | −$16.94M | −1,635.2% | −$22,427.93 | −$5.44M |
| Quarter | Revenue | Net income | EPS (diluted) |
|---|---|---|---|
| Q2 FY2026ended Jun 30, 2026 | $0.00 | −$1.12M | −$0.18 |
| Q1 FY2026ended Mar 31, 2026 | $0.00 | −$1.83M | −$0.29 |
| Q4 FY2025ended Dec 31, 2025 | $0.00 | −$2.90M | −$0.48 |
| Q3 FY2025ended Sep 30, 2025 | $0.00 | −$2.44M | −$0.39 |
| Q2 FY2025ended Jun 30, 2025 | $0.00 | −$2.62M | −$0.41 |
| Q1 FY2025ended Mar 31, 2025 | $0.00 | $3.01M | $0.49 |
| Q4 FY2024ended Dec 31, 2024 | $0.00 | −$7.18M | −$3.35 |
| Q3 FY2024ended Sep 30, 2024 | $0.00 | −$1.09M | −$0.57 |
Company profile
- Name
- Exicure, Inc.
- Ticker
- XCUR
- Exchange
- NASDAQ
- Industry (SEC SIC)
- Pharmaceutical Preparations
- Headquarters
- 2430 N. Halsted St., Chicago, IL 60614
- Incorporated in
- DE
- Fiscal year ends
- December
- SEC CIK
- 0001698530
Recent SEC filings
- Sep 16, 2026
- Aug 14, 2026
- Jun 30, 2026
- Jun 1, 2026
- May 29, 2026
- Apr 10, 2026
- Apr 2, 2026
- Mar 27, 2026
Frequently asked questions
What is Exicure's stock price?
Exicure (XCUR) closed at $565.86 on Oct 9, 2026, down 0.06% from the previous close of $566.22.
What is Exicure's market cap?
Exicure's market cap is $3.61B, based on a share price of $565.86 and 6.4M shares outstanding as of Jun 30, 2026.
How much revenue does Exicure make?
Exicure reported revenue of $0.00 for fiscal 2025, down 100.00% from fiscal 2024.
Does Exicure pay a dividend?
Exicure's recent filings report no dividends declared over the last four quarters.
Sources and methodology
Fundamentals come from Exicure, Inc.'s filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures